Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation

Lindy Biosciences is a Duke University start-up run by CEO Deborah Bitterfield (PhD MEMS, Pratt) based on technology developed in the lab of Professor Emeritus David Needham (MEMS, Pratt).